Why do some people become only mildly ill when they “catch” viral oder bacterial infections, whereas others are affected much more severely? How can we manage to predict the course of the disease, develop better therapies and thus protect and treat everyone as well as possible?

The team at our Cluster of Excellence RESIST  is conducting intensive research at the highest level to find answers to these important questions. The work is focussed on the most vulnerable: people who are particularly susceptible to infections. These include people with a congenital immunodeficiency, newborn babies, the elderly or patients whose immune system is suppressed for therapeutic reasons.